Titel och upphov Measuring and improving cost, cost-effectiveness, and cost-benefit for substance abuse treatment programs [Elektronisk resurs] : a manual
Utgivning, distribution etc. National Institutes of Health : National Institute on Drug Abuse, Bethesda, Md : 1999
Fysisk beskrivning
Serietitel - biuppslagsform NIH publication ; 99-4518
Anmärkning: Allmän
Anmärkning: Innehållsbeskrivning, sammanfattning Intense competition for limited substance abuse program funds, combined with increased scrutiny of program costs and outcomes, has created a need for better understanding of how costs and outcomes are related in substance abuse treatment. Programs are increasingly called on to show that their treatment of substance-abusing patients is a good investment of public and private funds. Program costs must be justified relative to program outcomes (and vice versa). (From the introduction)
Term
Indexterm - Okontrollerad
Institutionsnamn National Institutes of Health National Institute on Drug Abuse
ISBN
*000 am a a
*00115547
*007cr |||||||||||
*008070120s1999||||xxu||||es|||||||||1|eng||
*020 $a0-16-050141-5
*1001 $aYates, Brian T.
*24510$aMeasuring and improving cost, cost-effectiveness, and cost-benefit for substance abuse treatment programs$ba manual$h[Elektronisk resurs] :
*260 $aBethesda, Md :$bNational Institutes of Health : National Institute on Drug Abuse,$c1999
*300 $a124 s :$bill.
*440 $aNIH publication ;$v99-4518
*500 $aE-bok
*520 $aIntense competition for limited substance abuse program funds, combined with increased scrutiny of program costs and outcomes, has created a need for better understanding of how costs and outcomes are related in substance abuse treatment. Programs are increasingly called on to show that their treatment of substance-abusing patients is a good investment of public and private funds. Program costs must be justified relative to program outcomes (and vice versa). (From the introduction)
*650 4$aSubstance-related disorders
*650 4$aTreatment outcome
*650 4$aEconomics
*650 4$aCosts and cost analysis
*650 4$aCost-benefit analysis
*650 4$aUnited States
*653 $aDrogmissbruk
*653 $aVård
*653 $aBehandling
*653 $aKostnader
*653 $aEkonomi
*653 $aUSA
*7101 $aNational Institutes of Health
*7101 $aNational Institute on Drug Abuse$0124050
*85640$uhttps://archive.org/details/measuringimprovi0000yate$zFulltext
^
Det finns inga omdömen till denna titeln.
Klicka här
för att vara den första som skriver ett omdöme.